Post Critical Illness Dysphagia in the Intensive Care Unit (DysphagiaICU)

September 21, 2021 updated by: Waleed Al-Hazzani, St. Joseph's Healthcare Hamilton

Post Critical Illness Dysphagia in the Intensive Care Unit (Dysphagia-ICU): a Single Centre Prospective Cohort Study

The aims of the study are to determine: 1) the prevalence of ICU acquired dysphagia, 2) identify risk factors for ICU Acquired dysphagia, and 3) consequences of ICU acquired dysphagia including: ICU mortality, hospital mortality, days of mechanical ventilation, ICU length of stay, hospital length of stay, post extubation aspiration pneumonia, and rate of percutaneous endoscopic gastrostomy placed feeding tube (PEG-Tube) insertion, and/or total parenteral nutrition (TPN) and/or Dobhoff feeds.

Study Overview

Detailed Description

The RC will collect daily data on the use of advance life support, need for mechanical ventilation and outcomes (mortality, duration of mechanical ventilation, ICU length of stay, hospital length of stay). Enrolled patients will undergo a water sip test in the ICU and a videofluroscopic swallowing study (VFSS) performed by a registered speech-language pathologist (SLP). A VFSS is a videotaped or digitized dynamic fluoroscopic image that focuses on the oral, pharyngeal, laryngeal and upper esophageal swallow physiology. Patients will then be followed as two cohorts 1) patients that have dysphagia (or abnormal test) based on the VFSS, and 2) patients who have normal VFSS. We will then prospectively follow these two groups of patients during hospital stay censored at 30 days.

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • St. Joseph's Healthcare Hamilton

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Adults (18 years of age and older)
  2. Received mechanically ventilated for > 24 hours
  3. Have been extubated for >24 hours
  4. Hemodynamically stable (i.e. not requiring active resuscitation or vasoactive agents)
  5. Able to participate in VFSS - with n the first 7 days after successful extubation. (+/- 2 days)

Exclusion Criteria:

  1. Gastrostomy tube or a Gastro-jejunostomy tubes
  2. Current contraindication to oral feeding (eg. recent gastrointestinal surgeries as indicated by their surgeons)
  3. Being actively palliated
  4. Tracheostomy
  5. Neuromuscular condition associated with dysphagia: (e.g., amyotrophic lateral sclerosis, myasthenia gravis)
  6. Pre-existing history of dysphagia
  7. Ongoing respiratory support (defined as requiring ≥ 50% oxygen, bi-level positive airway pressure, or high flow nasal cannula) for 7 days or more after extubation.
  8. Caring physician declined

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: VFSS and Water Sip Test
Enrolled patients will undergo a water sip test and Videofluroscopy Swallow Test (VFSS)
VFSS is a radiological examination that can identify the presence, nature and severity of any abnormalities in oropharyngeal, laryngeal and upper esophageal swallow physiology. The VFSS will be administered via a standardized protocol by a registered speech-language pathologist (SLP). During the VFSS, the patient is seated upright and swallows a variety of consistencies (eg. liquids, semisolids and solids) and volumes of barium-coated foods. A dynamic fluoroscopic image will be digitally captured and recorded.
Other Names:
  • VFSS
The steps of the water sip test include; 1. The patient will be given 5 ml of water, and if tolerated 20 ml followed by 50 ml of water (thin fluid) and the patient is assessed for cough/chocking during or after swallowing, wet or weak cough after swallowing. 2. The patient is asked to produce sustained vowel /a/ before and after swallowing of water and voice change after swallowing will be observed and recorded.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dysphagia
Time Frame: Hospital Discharge or 30 days post VFSS
Defined as -abnormal VFSS scores resulting in need for modification of oral diet textures or non-oral means of nutrition and hydration provision.
Hospital Discharge or 30 days post VFSS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aspiration
Time Frame: Hospital Discharge or 30 days post VFSS
During drinking, eating, taking oral medication or other health professional-as documented in the clinical note by the treating physician
Hospital Discharge or 30 days post VFSS
Pneumonia
Time Frame: Hospital Discharge or 30 days post VFSS
Define as new pneumonia after extubation as noted in clinical chart
Hospital Discharge or 30 days post VFSS
Length of Stay
Time Frame: Hospital Discharge or 30 days post VFSS
ICU and Hospital
Hospital Discharge or 30 days post VFSS
PEG tube insertion or need for TPF or Dobhoff feeds
Time Frame: Hospital Discharge or 30 days post VFSS
• Percutaneous endoscopic gastrostomy placed feeding tube (PEG-Tube) insertion or need for TPF or Dobhoff feeds
Hospital Discharge or 30 days post VFSS
Mortality
Time Frame: Hospital Discharge or 30 days post VFSS
In ICU or In Hospital
Hospital Discharge or 30 days post VFSS
Reintubation
Time Frame: Hospital Discharge or 30 days post VFSS
Defined as reintubation within 30 days of original extubation during initial hospital admission. Reasons for reintubation will be recorded.
Hospital Discharge or 30 days post VFSS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Waleed Alhazzani, MD, MSc, McMaster University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 4, 2019

Primary Completion (ANTICIPATED)

September 1, 2022

Study Completion (ANTICIPATED)

December 1, 2022

Study Registration Dates

First Submitted

April 14, 2020

First Submitted That Met QC Criteria

April 14, 2020

First Posted (ACTUAL)

April 16, 2020

Study Record Updates

Last Update Posted (ACTUAL)

September 27, 2021

Last Update Submitted That Met QC Criteria

September 21, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dysphagia

Clinical Trials on VideoFlurosocopy Swallow Study

Subscribe